Skip to main content
EQ
NASDAQ Life Sciences

Equillium Registers 18.8M Shares for Resale by RA Capital, Creating Significant Overhang

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$1.92
Mkt Cap
$121.395M
52W Low
$0.27
52W High
$2.7
52W Position info
611% above low
Off High info
29% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

EQ has more than doubled off its 52-week low of $0.27.

Summary

Equillium filed an S-3 to register 18.88 million shares for resale by RA Capital, representing a significant potential dilution and creating an overhang on the stock.


Key Events · Financing and Capital Events · EQ

  • Resale Registration Filed

    Equillium filed an S-3 registration statement covering the resale of 18,878,101 shares of common stock by RA Capital Healthcare Fund, L.P.

  • Significant Potential Dilution

    The registered shares represent approximately 29.86% of the company's currently outstanding common stock, creating a substantial overhang on the market.

  • Follows Recent Private Placement

    These shares were acquired by RA Capital in a private placement that closed on March 13, 2026, for approximately $35.0 million, as previously disclosed in an 8-K filing.


Analysis · EQ · Life Sciences

This S-3 filing registers 18.88 million shares of common stock, including shares issuable from pre-funded warrants, for resale by RA Capital Healthcare Fund, L.P. These shares were acquired in a private placement on March 13, 2026, for approximately $35.0 million. While the company already received the proceeds from the private placement, this registration enables the selling stockholder to liquidate their position, representing a potential dilution of nearly 30% of outstanding shares. This creates a substantial overhang on the stock, despite the company's previously reported cash runway into 2029.

How filings like this one have moved

In the 30 days to Nov 15, 2026, 37.5% of the 3713 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, EQ was trading at $1.92 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $121.4M. The 52-week trading range was $0.27 to $2.70. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

EQ - Latest Insights

EQ
Nov 12, 2026, 4:20 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $1.34
Real-time Price: $1.25 info
Change: -$0.090 (-7%) info
Market Cap: $94.673M info
EQ
Oct 26, 2026, 5:09 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.29
Real-time Price: $1.25 info
Change: -$0.040 (-3%) info
Market Cap: $94.673M info
EQ
Oct 26, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.12
Real-time Price: $1.25 info
Change: +$0.1297 (+12%) info
Market Cap: $94.673M info
EQ
Oct 05, 2026, 5:06 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.42
Real-time Price: $1.25 info
Change: -$0.170 (-12%) info
Market Cap: $94.673M info
EQ
Oct 05, 2026, 4:05 PM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.51
Real-time Price: $1.25 info
Change: -$0.260 (-17%) info
Market Cap: $94.673M info